Jilin Aodong Pharmaceutical Group: Announcement on the issuance results of the first issue of 2024 medium-term notes (science and technology innovation notes)

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.